Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario
Sharifa Nasreen, Hannah Chung, Siyi He, et al.
Nature Microbiology (2022) Vol. 7, Iss. 3, pp. 379-385
Open Access | Times Cited: 231

Showing 26-50 of 231 citing articles:

Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
Peter Schmidt, Kristin Narayan, Yong Li, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 688
Open Access | Times Cited: 24
Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants
Zhen Yang, Shuo Zhang, Yuping Tang, et al.
Aging and Disease (2022) Vol. 13, Iss. 2, pp. 402-402
Open Access | Times Cited: 35
A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines
Xiao‐Feng He, Jiao Su, Yunan Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age
Timothy A. Bates, Pei Lu, Ye jin Kang, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111544-111544
Open Access | Times Cited: 29
Vaccination strategies and transmission of COVID-19: Evidence across advanced countries
Dongwoo Kim, Young Jun Lee
Journal of Health Economics (2022) Vol. 82, pp. 102589-102589
Open Access | Times Cited: 28
Characterizing the Spatiotemporal Heterogeneity of the COVID-19 Vaccination Landscape
Andrew Tiu, Zachary Susswein, Alexes Merritt, et al.
American Journal of Epidemiology (2022) Vol. 191, Iss. 10, pp. 1792-1802
Open Access | Times Cited: 28
Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview
Omid Gholizadeh, Saman Yasamineh, Parya Amini, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Decoupling of omicron variant infections and severe COVID-19
Shabir A. Madhi, Chikwe Ihekweazu, Helen Rees, et al.
The Lancet (2022) Vol. 399, Iss. 10329, pp. 1047-1048
Open Access | Times Cited: 27
A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity
Junyu Yang, Yixuan Ma, Yan Liu, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2735-2735
Open Access | Times Cited: 20
AGILE Platform: A Deep Learning-Powered Approach to Accelerate LNP Development for mRNA Delivery
Yue Xu, Shihao Ma, Haotian Cui, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 18
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19
Paulina Kapłonek, Deniz Cizmeci, Gaurav Kwatra, et al.
Nature Immunology (2023) Vol. 24, Iss. 7, pp. 1161-1172
Open Access | Times Cited: 17
Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants
Tiffany Barnes, Tyler Brady, Nicolette Schuko, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 16
Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities
Mohammad Shah Alam
Heliyon (2023) Vol. 9, Iss. 2, pp. e13285-e13285
Open Access | Times Cited: 15
Modeling COVID-19 dynamics in the Basque Country: characterizing population immunity profile from 2020 to 2022
Bechir Naffeti, Zeineb Ounissi, Akhil Kumar Srivastav, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
The Effect of Compulsory Schooling on Vaccination Against COVID
Daniel Monsees, Hendrik Schmitz
Health Economics (2025)
Open Access
Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai
Bo Zheng, Bronner P. Gonçalves, Pengfei Deng, et al.
eLife (2025) Vol. 13
Open Access
Assessment of COVID-19 Vaccine Effectiveness Against SARS-CoV-2 Infection, Hospitalization and Death in Mexican Patients with Metabolic Syndrome from Northeast Mexico: A Multicenter Study
Beatriz Silva-Ramírez, Katia Peñuelas-Urquides, Brenda Leticia Escobedo-Guajardo, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 244-244
Open Access
No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway
Lamprini Veneti, Beatriz Valcárcel Salamanca, Elina Seppälä, et al.
International Journal of Infectious Diseases (2021) Vol. 115, pp. 178-184
Open Access | Times Cited: 34
A comparison of seasonal influenza and novel Covid-19 vaccine intentions: A cross-sectional survey of vaccine hesitant adults in England during the 2020 pandemic
Vivi Antonopoulou, Louis Goffe, Carly Meyer, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 25
Higher COVID-19 Vaccination Rates Are Associated with Lower COVID-19 Mortality: A Global Analysis
Ilir Hoxha, Riaz Agahi, Altina Bimbashi, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 74-74
Open Access | Times Cited: 25
Co-incidence of BA.1 and BA.2 at the start of Singapore's Omicron wave revealed by Community and University Campus wastewater surveillance
Feng Jun Desmond Chua, Se Yeon Kim, Eric Hill, et al.
The Science of The Total Environment (2023) Vol. 875, pp. 162611-162611
Open Access | Times Cited: 14
A Multiplexed SERS Microassay for Accurate Detection of SARS-CoV-2 and Variants of Concern
Courtney Vedelago, Junrong Li, Kym Lowry, et al.
ACS Sensors (2023) Vol. 8, Iss. 4, pp. 1648-1657
Open Access | Times Cited: 14
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
Waning of 2-Dose BNT162b2 and mRNA-1273 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Accounting for Depletion-of-Susceptibles Bias
Kristin L. Andrejko, Jake M. Pry, Jennifer F. Myers, et al.
American Journal of Epidemiology (2023) Vol. 192, Iss. 6, pp. 895-907
Open Access | Times Cited: 12
COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization
Pierre‐Philippe Piché‐Renaud, Sarah Swayze, Sarah A. Buchan, et al.
PEDIATRICS (2023) Vol. 151, Iss. 4
Closed Access | Times Cited: 12

Scroll to top